Dr Reddy’s shares slide 7% after delay in semaglutide supplies over quality concerns
Shares of Dr Reddy’s Laboratories fell 6.5% to Rs 1,261 on the BSE on Thursday after the company said commercial supplies of its semaglutide product will be delayed following a quality-related issue linked to the active pharmaceutical ingredient (API) used in certain batches. In an exchange filing, the company said certain batches of semaglutide were […]